Syzygy Magic Mushrooms Europe

Syzygy Magic Mushrooms Europe (Psilocybe Cubensis, Syzygy) is a strain that dates back to the ’70s and is named after the famous ethnobotanist/mystic/psychonaut Terrence McKenna’s company. Syzygy was the name of the spore vendor that the McKenna brothers owned. Since the death of Terrence Mckenna and the passing of time, this strain was lost but it has been found and revived recently.

Syzygy is a healthy and resilient cubensis strain that was originally collected from the Amazonian strains of Stropharia Cubensis. Our staff reported that Syzygy shrooms provide a good balance of warm visuals and spiritual experience. Expect an eye-opening experience that will re-calibrate your train of thought.

Syzygy (Psilocybe cubensis) – History, Origins & European Legal Overview

Syzygy is a historic variety of Psilocybe cubensis that traces its roots back to the 1970s psychedelic research and ethnobotanical movement. The name “Syzygy” is associated with the company founded by Terence McKenna and his brother, who were influential figures in modern psychedelic culture.

The Syzygy brand was originally connected to a spore distribution business during the early wave of psychedelic exploration in North America. Over time, the genetics were reportedly lost and later revived within cultivation communities.

Historical Background

The Syzygy name became widely recognized during the era when Psilocybe cubensis was often referred to as Stropharia cubensis in older literature. Early collections of cubensis strains frequently originated from tropical regions, including areas of the Amazon basin.

While Syzygy is not a formally classified scientific subspecies, it represents a cultivated genetic line preserved through community sharing and selective breeding.

Taxonomy & Classification

• Species: Psilocybe cubensis

• Former Classification: Stropharia cubensis (historical naming)

• Common Name: Syzygy

• Climate Preference: Tropical to subtropical

• Genetic Type: Cultivated cubensis variety

Most cubensis “strains” are stabilized cultivation lines rather than distinct biological subspecies.

Reported Characteristics

Within educational and community discussions, Syzygy is commonly described as:

• A resilient and adaptable cubensis variety

• Consistent fruiting performance in cultivation contexts

• Comparable psilocybin levels within the typical cubensis range

Anecdotal reports often mention:

• Balanced sensory enhancement

• Visual pattern perception

• Emotional introspection

• Altered perspective and cognitive shifts

As with all psychedelic substances, individual responses vary significantly depending on dosage, environment, psychological state, and physiology.

Legal Status in Europe

Psilocybin-containing mushrooms are illegal in most European countries.

Examples include:

• Germany – Controlled substance

• France – Illegal possession and distribution

• United Kingdom – Class A under the Misuse of Drugs Act

• Netherlands – Dried mushrooms illegal; regulated truffle market

Always verify current regulations within your specific jurisdiction.

Scientific Research Context

Modern psilocybin research is conducted under strict medical supervision at institutions such as:

• Johns Hopkins University

• Imperial College London

Current studies are examining potential therapeutic applications for depression, PTSD, addiction, and end-of-life anxiety in controlled clinical environments.